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Abstract
The correct biogenesis and localization of Pma1 at the plasma membrane is essential for yeast growth. A subset of PMA1
mutations behave as dominant negative because they produce aberrantly folded proteins that form protein aggregates,
which in turn provoke the aggregation of the wild type protein. One approach to understand this dominant negative effect
is to identify second-site mutations able to suppress the dominant lethal phenotype caused by those mutant alleles. We
isolated and characterized two intragenic second-site suppressors of the PMA1-D378T dominant negative mutation. We
present here the analysis of these new mutations that are located along the amino-terminal half of the protein and include a
missense mutation, L151F, and an in-frame 12bp deletion that eliminates four residues from Cys409 to Ala412. The results
show that the suppressor mutations disrupt the interaction between the mutant and wild type enzymes, and this enables
the wild type Pma1 to reach the plasma membrane.
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Introduction
The proton pumping H+- ATPase of Saccharomyces cerevisiae,
Pma1 [1], is an electrogenic P-type cation pump [2] that is
essential for the uptake of nutrients and the regulation of
intracellular pH [3]. It is well established by homology modeling
based on X-ray diffraction studies of different ATPases that
sequence homology in P-type ATPases family is restricted to
discrete regions but that the overall structure is conserved even
among different subfamilies [4]. Pma1 is an abundant integral
membrane protein destined to the cell surface where it spans the
lipid bilayer with 10 transmembrane segments [5]. The cytoplas-
mic part of the protein contains three functional domains: the
nucleotide-binding domain (N-domain), the phosphorylation
domain (P-domain), and the actuator domain (A-domain) [6]. In
addition, Pma1 as well as other P-type ATPases contains a C-
terminal regulatory domain [7]. Due to its abundance Pma1
constitutes a major cargo of the secretory pathway and its amount
in the plasma membrane is tightly controlled [8]. In fact
PMA1overexpression induces cell stress and, as a consequence,
the activation of the Hog1-MAPK pathway [9].
Pma1 is biosynthetically inserted into the endoplasmic reticulum
(ER) membrane and after folding and homo-oligomerization
travels to its final destination through a series of transport vesicles
[10], [11], [12]. In its way to the membrane it becomes associated
with lipid rafts, a process that occurs in the ER [13]. Correct
oligomerization of Pma1, as well as its stability in the plasma
membrane, requires long-chain fatty acid containing lipids [12],
[14], [15], [16], but the Pma1 regions involved in the formation of
oligomers remain to be determined. Mutant Pma1 proteins that
are not properly folded do not reach the plasma membrane but
rather remain accumulated in ER-derived structures that stain
with anti Kar2 antibodies [17].
PMA1, the gene coding for the plasma membrane H+-ATPase,
is an essential gene that has been extensively studied by site-
directed mutagenesis [18]. Among the large number of mutants
generated several point mutations have been shown to cause cell
growth arrest even in the presence of a co-expressed wild type
PMA1 allele. Particularly, mutations altering Asp378, a residue
conserved in all P-type ATPases, exhibit this dominant lethal
phenotype [17], [19], [20], [21]. The Asp378 residue is located in
the central cytoplasmic loop of the protein and is involved in the
formation of the aspartyl-phosphate intermediate during the
catalytic cycle of the enzyme. PMA1 alleles carrying changes in
this residue produce misfolded proteins that are retained in the ER
[17], [20], [21] and finally degraded by the Endoplasmic
Reticulum Associated Degradation (ERAD) machinery [22],
[23]. The efficient degradation of the mutant Pma1 variants
requires in addition an intact autophagy pathway [23]. The
ERAD mechanism involves the recognition of the misfolded
proteins in the ER, their ubiquitination and retrotranslocation into
the cytoplasm, and the degradation of the proteins by the
proteasome [24], [25], [26], [27], One example of these dominant
lethal alleles is PMA1-D378T whose expression not only produces
a misfolded protein [22], [28], but also interferes with the folding
of the wild type protein leading to the aggregation of both mutant
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and wild type proteins, and their slow degradation by ERAD [28].
As a consequence, Pma1 protein is depleted from the cell surface
causing growth arrest. In an attempt to understand the mechanism
of formation of protein aggregates and how dominant lethal Pma1
affects the wild type enzyme we have isolated intragenic revertants
of dominant Pma1 mutants. We have previously described a
suppressor mutation for PMA1-D378T dominant lethality,
Trp859stop, which disrupts the formation of oligomers between
the mutant and wild type enzymes [28]. The Trp859stop
suppressor mutation deletes transmembrane segment 10 (TM10)
and the C-terminus of the Pma1 protein suggesting the
involvement of this transmembrane segment in the oligomeriza-
tion of the enzyme. Here, we describe and characterize two new
suppressor mutations for PMA1-D378T mutant that localize to
TM2 (L151F) and the N-domain (DC409-A412).
Materials and Methods
Yeast Strains and Growth Conditions
Yeast strain BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0)
purchased from EUROSCARF (Frankfurt, Germany) was used in
all the experiments. Synthetic media containing 0.67% Yeast
Nitrogen Base w/o amino acids, 2% dextrose (SD), 2% raffinose
(SR) or 2% galactose (SG) and the appropriate requirements were
used. Standard methods for yeast transformation, culture and
manipulation were used [29]. For growth tests the different yeast
strains were grown on SR for 24 h, suspended in water to an
OD660 = 0.1 and 5 ml were dropped on SD and SG agar plates.
In cycloheximide-chase experiments the different transformants
were grown in SR medium to mid-exponential phase
(OD660 = 0.8–1), galactose was added to the culture at a final
concentration of 2% and cells were cultured during 4 h to induce
the expression of the PMA1 alleles. Cycloheximide was added to a
final concentration of 200 mg/ml and samples of 50 OD were
taken at the indicated times and frozen in liquid nitrogen.
Plasmids
Plasmids pIB2010, pIB2018, pIB2019 and pIB2039 are
derivatives of the LEU2 centromeric plasmid pRS315 [30] and
carry myc-tagged PMA1-D378T (pIB2010) or PMA1 (pIB2018)
and HA-tagged PMA1-D378T (pIB2019) or PMA1 (pIB2039)
alleles under the control of the GAL1 promoter. The construction
of these plasmids has been reported [23], [28]. Site-directed
mutagenesis was used to introduce the L151F and DC409-A412
mutations in a 4.3 kb XhoI-HindIII fragment containing the HA-
tagged PMA1 gene subcloned into pSK vector (Stratagene, La
Jolla, CA) using the QuickChangeTM method developed by
Stratagene and modified as in [31]. The correct introduction of
the mutations was verified by sequencing. Plasmids carrying the
single mutants HA-pma1-L151F and HA-pma1-DC409-A412
under the control of the GAL1 promoter were generated by
cloning a 0.7 kb EcoRI-XhoI fragment containing the entire GAL1
promoter [32] and the 4.3 kb XhoI-HindIII fragment containing
the corresponding mutagenized HA-tagged PMA1 allele into the
EcoRI and HindIII sites of the URA3 single copy plasmid pRS316
[30].
Isolation and Sequencing of Revertants from PMA1-
D378T
Wild type yeast strain BY4741 was transformed with 50 mg of
pIB2010 using the lithium acetate procedure [33]. Approximately
12,000 transformants were selected in SR medium. Transformed
cells were replica plated onto SG medium to induce the expression
of the dominant lethal allele. Plasmids were rescued [29] from
those yeasts able to grow on galactose medium and retransformed
to confirm their ability to suppress the dominant lethal phenotype
of the D378T mutant ATPase. Inserts contained in the suppressor
plasmids were sequenced.
Cell Lysis and Immunoblotting
Total yeast protein extracts were prepared by vortexing with
glass beads in buffer containing 50 mM Tris-HCl pH 8, 5 mM
EDTA and a protease inhibitor cocktail (Roche, Manheim,
Germany). The homogenate was cleared from intact cells by
centrifugation for 10 min at 3006g. The supernatant was then
centrifuged at 15,0006g for 20 min. The resulting pellet was
resuspended in buffer containing 20% w/v glycerol, 50 mM Tris-
HCl pH 8, 5 mM EDTA, 2 mM DTE and protease inhibitor
cocktail. Proteins were resolved in 8% SDS-polyacrylamide gel
electrophoresis [34] and transferred to a PVDF membrane
(Immobilon P, Millipore) for immunodetection using mouse
monoclonal 12CA5 (Roche, Manheim, Germany) against the
HA epitope, rabbit polyclonal antibody against the myc epitope
(Sigma, St Louis, MO), rabbit polyclonal anti-Kar2 (Santa Cruz
Biotechnology) or mouse monoclonal anti-Pma1 [35]. Immuno-
detection was performed using the ECL Western blot analysis
system (Amersham Biosciences, Sunnyvale, CA) according to the
manufacturer’s protocol. Protein concentration was determined by
the Bradford method [36] with the Bio-Rad Protein Assay reagent
(Bio-Rad, Hercules, CA) and bovine IgG as standard.
Immunofluorescence
Yeast cells coexpressing HA-tagged and myc-tagged PMA1
alleles were cultured in SR medium overnight at 30uC, and
galactose was added to the culture at a final concentration of 2%
for 4 h at 30uC to induce the expression of GAL1-dependent genes.
Yeast cells were fixed and stained for immunofluorescence as
described [37], using mouse monoclonal 12CA5 anti-HA and
rabbit polyclonal anti-myc antibodies as primary antibodies,
followed by FITC-conjugated goat anti-mouse or rhodamine-
conjugated goat anti-rabbit (Jackson ImmunoResearch, West
Grove, PA). Images were obtained with a Zeiss Axiofot microscope
and further processed with Adobe Photoshop 7.0.
Blue Native Gel Electrophoresis
Solubilization of membrane proteins for blue native gel
electrophoresis was performed using a modification of the method
described in [38]. Twenty mg of protein were solubilized in 20 ml
of buffer containing 50 mM Tris-HCl pH 7.4, 5 mM EDTA,
750 mM 6-aminocaproic acid, 1 mM PMSF and either 3% Triton
X-100 or 1% SDS. Samples were incubated at 4uC in the case of
Triton X-100 solubilization, or at room temperature in the case of
SDS, for 30 minutes and centrifuged for 5 min at 15,0006g.
Proteins in the supernatant were separated on 4–16% polyacryl-
amide gradient gels using NativePAGE Novex Bis-Tris System
with NativeMark Unstained Protein Standard (Invitrogen, Carls-
bad, CA). NativePAGE Sample Buffer was supplemented with
750 mM 6-aminocaproic acid and 0.75% G-250 Sample Additive.
Proteins were transferred to PVDF and analyzed by immunoblot-
ting.
Results
Isolation of Suppressors of the Dominant Lethal
Phenotype Caused by PMA1-D378T
Revertants of the dominant lethal phenotype caused by the
PMA1-D378T mutation were obtained as described in Materials
and Methods. Briefly, wild type cells carrying the dominant lethal
Second-Site Mutations Prevent Aggregation of Pma1
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e67080
PMA1-D378T allele under the control of the GAL1 promoter were
grown in raffinose medium and replica plated to galactose-
containing plates. From 12,000 colonies analyzed, 10 were able to
grow on galactose. Plasmid DNA was isolated from those colonies
to determine if they were full revertants or either intra- or
extragenic suppressors. Upon retransformation and sequencing it
was found that 3 of the revertants were due to second-site
mutations in the PMA1-D378T mutant allele while the rest were
reversions to wild type.
One of the suppressor mutations found is a deletion of 25 base
pairs, from 1934C to 1958C, in the P-domain of the Pma1 protein.
The deletion produces a frame-shift that creates a stop codon and
leads to a truncated protein with an apparent molecular weight of
80 kDa. This frameshift mutation, renders a Pma1 variant lacking
six transmembrane segments, TM5 to TM10, and the carboxy-
terminal regulatory domain. Several C-terminal truncations of
Pma1 have been constructed and analyzed in the past [27], [39],
with respect to their trafficking, stability and degradation. For this
reason we did not pursue any further the characterization of this
suppressor. Another suppressor mutation found is a missense
mutation that causes a leucine to phenylalanine change at amino
acid 151 (L151F). Finally, a third suppressor mutation is a deletion
of 12 base pairs that leads to loss of four residues, Cys409, Leu410,
Ala411 and Ala412. Figure 1A depicts the location of the
suppressor mutations. The missense mutation L151F is located
within transmembrane segment TM2. Genetic evidence suggests
that the first and second transmembrane segments of Pma1 form a
helical hairpin with important structural determinants that
contribute to its overall flexibility [40]. The DC409-A412 deletion,
located in the N-domain, starts 31 residues downstream of Asp378
where the formation of the catalytic intermediate takes place.
Biochemical and genetic evidences suggest that Cys409 is an
important determinant in the local structure surrounding the
phosphorylation site [41]. Sequence comparison (Figure 1B) shows
that Leu151 is conserved in all the H+-ATPases. Among the
amino acids eliminated by the DC409-A412 deletion, Ala411 and
Ala412 are also conserved in all the H+-ATPases while conser-
vation of Cys409 and Leu410 is restricted to fungal H+-ATPases.
In Figure 2 the growth of wild type cells transformed with the
plasmids harboring the intragenic suppressors pma1-D378T/
L151F and pma1-D378T/DC409-A412 shows how the overex-
pression of these new alleles allows growth on galactose-containing
medium.
As mentioned above not only mutations altering the Asp378
residue but also other point mutations in the PMA1 gene exhibit a
dominant lethal phenotype [19]. We then asked whether the
suppressor mutations found here are able to suppress other
dominant lethal mutations or are specific of D378T. To answer
this question we combined in cis the L151F and DC409-A412
suppressor mutations with several dominant lethal mutations,
namely D378E, K474R, D560N, D634N and R695L. Dominant
lethality was suppressed in all cases indicating that the suppressor
mutations L151F and DC409-A412 are not specific for the D378T
allele. The suppression of mutations D560N and R695L is shown
as an example (Figure S1).
Characterization of the Suppressors
Dominant lethal PMA1 alleles render misfolded proteins that
are retained in the ER [17], [20], and targeted for degradation by
ERAD [22], [27], [23]. To characterize the mechanism of
suppression of the new mutations we first analyzed whether the
revertant enzymes containing the D378T/L151F and D378T/
DC409-A412 mutations could exhibit a reduced expression in
galactose medium as compared with that of the dominant lethal
Pma1-D378T protein. We compared the extent of induction
during 4 h in galactose-containing medium of the GAL1-driven
PMA1 alleles: wild type, D378T, D378T/L151F and D378T/
DC409-A412. As can be seen in Figure 3 the Pma1 variants
encoded by these alleles are induced to a similar extent when the
cells are shifted to galactose. This result indicates that the
suppression observed cannot be explained by low or lack of
induction of the revertant proteins. Next we explored the
possibility that the revertant enzymes could exhibit an increased
degradation rate as compared with the Pma1-D378T mutant
protein. For this purpose we performed cycloheximide-chase
analysis in wild type cells expressing each of the mentioned alleles.
After growth in raffinose medium the expression of the mutant
proteins was induced with galactose for 4 hour and the amount of
remaining myc-tagged Pma1 variants after addition of cyclohex-
imide was examined by western blot along 6 hour. Figure 4 shows
that the stabilities of Pma1-D378T/L151F and Pma1-D378T/
DC409-A412 proteins showed no significant difference with that of
Pma1-D378T. The stability of the mutant proteins was also
determined in cells lacking Ubc7, an ubiquitin conjugating
enzyme, required for ERAD of Pma1 [23], in order to assess the
dependence of their degradation on ERAD. The stabilization
observed for the mutant proteins in the ubc7 background (Figure
S2) suggests the involvement of the ERAD mechanism.
We next analyzed the subcellular localization of the mutant
proteins by indirect immunofluorescence. Wild type cells were co-
transformed with plasmids containing HA-tagged wild type PMA1
and each of the myc-tagged double mutant PMA1 alleles. Cells co-
transformed with the wild type and dominant lethal PMA1-D378T
alleles were used as control. Expression of dominant PMA1 alleles
has been extensively shown to lead to the formation of intracellular
ER-derived punctate structures that contain the mutant protein
and the co-expressed wild type protein [17], [20], [42], [28]. Cells
were grown in raffinose and shifted to galactose-containing
medium to allow expression of the GAL1-driven PMA1 alleles
contained in the plasmids. The location of the HA- and myc-
tagged proteins was analyzed after 4 h induction. As can be seen in
Figure 5, in cells expressing the alleles containing both mutations,
D378T and one of the suppressor mutations, the co-expressed
HA-tagged Pma1 localized to the plasma membrane whereas the
myc-tagged double mutant proteins remained in intracellular
punctate structures. In control cells, containing both HA-Pma1
and myc-Pma1 the antibodies decorated the plasma membrane, as
expected, whereas when HA-Pma1 and myc-Pma1-D378T were
co-expressed the anti-HA and anti-myc antibodies decorated the
punctate structures as described. These results suggest that the
presence of the suppressor mutations abolishes the co-retention of
wild type Pma1 and permits its normal traffic to the plasma
membrane allowing cell growth. None of the two suppressor
mutations however allow the mutant proteins to escape, not even
partially, from the punctate structures.
Characterization of the Single Mutant Proteins
To learn more about the impact of the second-site mutations on
the Pma1 protein we constructed PMA1 alleles containing only the
suppressor mutations and studied the degradation rate and
subcellular localization exhibited by the single mutant proteins,
Pma1-L151F and Pma1-DC409-A412. The single mutant alleles
were constructed by site-directed mutagenesis, tagged with the HA
epitope at the amino terminus, and cloned under the control of the
GAL1 promoter in a centromeric plasmid. Growth of cells carrying
the single mutant PMA1 alleles can be seen in Figure 6. Half-life of
the mutant proteins was determined by cycloheximide pulse-chase
experiments after 4 h induction in galactose-containing medium.
Second-Site Mutations Prevent Aggregation of Pma1
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The degradation rate of the Pma1-L151F protein was comparable
to that of the wild type protein. In the case of Pma1-DC409-A412
its degradation rate was accelerated as compared with that of the
mutant Pma1-D378T (Figure 7). When the subcellular localization
of the mutant proteins was analyzed by indirect immunofluores-
cence we observed that while in cells expressing HA-Pma1-L151F
the anti-HA antibody stained the plasma membrane, HA-Pma1-
DC409-A412 mutant protein remained in intracellular punctate
structures (Figure 8). These results indicate that cells expressing
Pma1-L151F mutant protein behave as wild type with respect to
growth. Also, the stability and traffic to the plasma membrane of
the isolated L151F mutant are similar to those of the wild type
protein, while the variants carrying the DC409-A412 deletion,
whether as the single mutation or in cis with the D378T mutation,
remain retained in the ER.
The Double Mutant Proteins Pma1-D378T/L151F and
Pma1-D378T/DC 409-A412, and the Single Pma1-DC409-
A412 Form Aggregates
We have observed by indirect immunofluorescence (see above)
that the double mutant proteins Pma1-D378T/L151F and Pma1-
D378T/DC409-A412 as well as the single mutant Pma1-DC409-
A412 are retained in intracellular punctate structures while the
accompanying wild type Pma1 reaches the plasma membrane.
These results, together with previously reported data [28] showing
the formation of aggregates containing mutant Pma1 proteins
carrying different dominant lethal mutations, prompted us to
analyze the nature of the oligomers formed by the mutant
ATPases expressed from the suppressor alleles and the co-
expressed wild type proteins. For this purpose, membrane proteins
prepared from strains co-expressing a myc-tagged double mutant
and a wild type HA-Pma1 were extracted with a non-ionic
Figure 1. Mutations that suppress the dominant lethal phenotype of PMA1-D378T allele. A) Location of the suppressor mutations found
in the revertants. The positions where suppressor mutations create a missense mutation (closed circle) or deletions (open circles) are shown on a
topological model of the ATPase. The position of the original mutation D378T (open square) is also shown. The scheme shows the proposed
functional domains of the Pma1 protein as extrapolated from the crystal structure of the Arabidopsis thaliana homologous ATPase: a transmembrane
domain with ten helices and three cytosolic domains named A (actuator domain), P (phosphorylation domain) and N (nucleotide-binding domain). B)
Alignment of the sequences of several H+-ATPase family members in the region surrounding mutations L151F and DC409-A412.
doi:10.1371/journal.pone.0067080.g001
Figure 2. Growth of cells carrying wild type and mutant Pma1
variants. Drop test for growth on galactose of yeast strains carrying
the indicated PMA1 alleles, all of them under the control of the GAL1
promoter. The different strains were grown in SR medium for 24 h,
suspended in water to an OD660 = 0.1 and 5 ml were dropped on SD and
SG agar plates. Identical results were obtained with three independent
transformants.
doi:10.1371/journal.pone.0067080.g002
Figure 3. GAL1-induced expression of wild type and mutant
Pma1 variants. Yeast strains carrying the indicated myc-tagged PMA1
alleles, all of them under the control of the GAL1 promoter, were grown
in SR medium and derepressed in galactose containing medium for 4 h
to induce the expression of the PMA1 alleles. Samples were taken at
times zero and 4 h of induction and total yeast membranes were
prepared and analyzed by Western blot with anti-myc and anti-Kar2
antibodies. The same samples were loaded in a duplicate gel and
immunoblotted with monoclonal anti-Pma1 antibody.
doi:10.1371/journal.pone.0067080.g003
Second-Site Mutations Prevent Aggregation of Pma1
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e67080
detergent, in order to preserve native structures, and subjected to
blue native gel electrophoresis (BN-PAGE) [38] to examine the
migration of the oligomers formed by Pma1. This method allows
the preservation of the tertiary and quaternary structures of
protein complexes but, nevertheless, allows the separation of the
complexes according to their molecular weight. Microsomal
membranes from cells co-expressing the myc-tagged double
mutant alleles and the HA-tagged Pma1 were treated with Triton
X-100 and analyzed by BN-PAGE and immunoblot. Membranes
from cells expressing both myc- and HA-tagged wild type Pma1 or
myc-Pma1-D378T and HA-Pma1 were also analyzed as control.
In addition, duplicate samples of the membranes were treated with
SDS and run in parallel. The results, presented in Figure 9A,
showed that Triton X-100 treated membranes of wild type HA-
Pma1 co-expressed with wild type myc-Pma1 presented two bands
that correspond to the monomeric and oligomeric forms of Pma1
(Figure 9A, lanes 1 and 9). This behavior of Pma1, that migrates in
BN-PAGE as a protein larger than its reported 100 kDa size has
been previously reported [12], [28]. On the other hand, wild type
HA-Pma1 showed a diffuse smear when co-expressed with the
mutant myc-Pma1-D378T (Figure 9A, lanes 2 and 10). The
corresponding samples treated with SDS showed predominantly
the monomeric form in the case of the co-expressed wild type
forms (Figure 9A, lanes 3 and 11), and in the case of HA-Pma1 co-
expressed with the dominant lethal allele PMA1-D378T, we
observed, in addition to the monomer, a smear of high molecular
weight aggregates (Figure 9A, lanes 4 and 12), indicating that these
forms are insoluble even in SDS. This behavior, due to the
presence of oligomeric structures different from the wild type
oligomer and formed when myc-Pma1-D378T is present, is
attributed to the aberrant folding of the mutant protein that in
Figure 4. Stability of the wild type and mutant Pma1 variants. Yeast strains carrying the indicated myc-tagged PMA1 alleles under the control
of the GAL1 promoter, were grown in SR medium and derepressed in galactose containing medium for 4 h to induce the expression of the different
Pma1 proteins. After addition of cycloheximide, samples were taken at the indicated times and total yeast membranes prepared and analyzed by
Western blot with anti-myc antibodies. A representative blot of each cycloheximide-chase experiment is shown. Densitometric analysis of the
immunoblots was performed and remaining Pma1 at different times was referred to the amount before adding cycloheximide (t = 0). Wild type
(diamonds), Pma1-D378T (circles), Pma1-D378T/L151F (squares), Pma1-D378T/DC409-A412 (triangles). Shown are the means and standard deviations
of three independent experiments calculated with GraphPad Prism5.
doi:10.1371/journal.pone.0067080.g004
Figure 5. Localization of wild type and mutant proteins. Yeast
strains expressing GAL1-driven HA-tagged wild type Pma1 and GAL1-
driven myc-tagged wild type Pma1, dominant lethal Pma1-D378T, or
double mutant proteins Pma1-D378T/L151F and Pma1-D378T/DC409-
A412 were processed for indirect immunofluorescence microscopy as
described in Materials and Methods. Monoclonal anti-HA and FITC-
conjugated secondary antibodies were used to detect HA-Pma1 while
polyclonal anti-myc and rhodamine-conjugated secondary antibodies
were used to detect the myc-tagged Pma1variants.
doi:10.1371/journal.pone.0067080.g005
Figure 6. Growth of cells carrying wild type and single mutant
Pma1 variants. Drop test for growth on galactose of yeast strains
carrying the indicated PMA1 alleles, all of them under the control of the
GAL1 promoter was performed as in Figure 2. Identical results were
obtained with three independent transformants.
doi:10.1371/journal.pone.0067080.g006
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turn induces misfolding of the co-expressed wild type [28]. When
the myc-tagged double mutant proteins Pma1-D378T/L151F and
Pma1-D378T/DC409-A412 were analyzed we observed high
molecular weight aggregates both in Triton X-100 and SDS
treated membranes (Figure 9A, lanes 13, 14, 15 and 16) very
similar to those observed for myc-Pma1-D378T and the co-
expressed wild type. However, wild type HA-Pma1 co-expressed
with the myc-tagged double mutants behaved similar to a wild
type both in Triton X-100 (Figure 9A, lanes 5 and 6) where it can
be appreciated the monomeric and oligomeric bands, and in SDS
(Figure 9A, lanes 7 and 8), where only the monomer was observed
indicating that the presence of the suppressor mutation attenuates
the formation of those high molecular weight aggregates with the
accompanying wild type Pma1.
When the behavior of the single mutants co-expressed with the
wild type was analyzed it was found that the wild type
accompanying either one of the single mutant variants HA-
Pma1-L151F or HA-Pma1-DC409-A412 exhibited a wild type
pattern in Triton X-100 and SDS treated membranes (Figure 9B,
lanes 1, 2, 3, and 4). The analysis of Pma1-DC409-A412 showed
the existence of high molecular weight aggregates both in Triton
X-100 and SDS treated membranes (Figure 9B, lanes 6 and 8)
very similar to those observed for myc-Pma1-D378T and the co-
expressed wild type and for the double mutant proteins Pma1-
D378T/L151F and Pma1-D378T/DC409-A412. At a difference
with these double and single mutant variants, the mutant protein
Pma1-L151F behaved as a wild type protein in all conditions
(Figure 9B, lanes 5 and 7). The results obtained with the single
mutant proteins are consistent with those obtained by immuno-
fluorescence and cycloheximide pulse-chase experiments, where
Pma1-DC409-A412 was found in the punctate structures charac-
teristic of the aggregated protein Pma1-D378T and showed
increased instability, while Pma1-L151F was detected in the cell
surface and was as stable as the wild type Pma1.
Discussion
Dominant lethal mutations in the essential gene PMA1 cause an
aberrant conformation of the encoded protein that results in its
retention in the ER [17], [20], [21], and degradation by the
ERAD mechanism because of their recognition by the ER quality
control [22], [27], [23]. It is accepted that the misfolded proteins
expressed from these dominant lethal alleles, such as PMA1-
D378T, hetero-oligomerize with the wild type enzyme and this is
the cause of the co-retention of both mutant and wild type proteins
[22], [28]. Here, we performed a genetic screening to isolate
intragenic suppressors of the PMA1-D378T mutation expressed
from a GAL1 conditional promoter. We identified two suppressor
mutations that restored the cells ability to grow on galactose, one
of them, L151F, predicted to lie in TM2 and the other, DC409-
A412, located in the N-domain of the protein, both affecting
conserved positions of the fungal P-type ATPase protein family.
We also analyzed the stability and subcellular localization of the
double mutant Pma1 variants. Our results show that the second-
site suppressor mutations did not significantly modified the
stability of the mutant proteins, that are degraded, in a Ubc7-
dependent manner, at a rate similar to that of the Pma1-D378T
Figure 7. Stability of the wild type and single mutant Pma1 variants. Yeast strains carrying the indicated HA-tagged PMA1 alleles under the
control of the GAL1 promoter, were grown in SR medium and derepressed in galactose containing medium for 4 h to induce the expression of the
different Pma1 proteins. Samples were taken and processed as indicated in Figure 4 and analyzed by Western blot with anti-HA antibodies. A
representative blot of each cycloheximide-chase experiment is shown. Densitometric analysis of the immunoblots was performed and remaining
Pma1 at different times was referred to the amount before adding cycloheximide (t = 0). Wild type (diamonds), Pma1-D378T (circles), Pma1-L151F
(squares), Pma1-DC409-A412 (triangles). Shown are the means and standard deviations of three independent experiments calculated with GraphPad
Prism5.
doi:10.1371/journal.pone.0067080.g007
Figure 8. Localization of wild type and single mutant proteins.
Yeast strains expressing GAL1-driven myc-tagged wild type Pma1 and
GAL1-driven HA-tagged single mutant proteins Pma1-L151F or Pma1-
DC409-A412, were processed for indirect immunofluorescence micros-
copy as described in Materials and Methods. Monoclonal anti-HA and
FITC-conjugated secondary antibodies were used to detect HA-Pma1
while polyclonal anti-myc and rhodamine-conjugated secondary
antibodies were used to detect the myc-tagged Pma1variants.
doi:10.1371/journal.pone.0067080.g008
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variant. Our results also show that neither suppressor mutation
corrected the intrinsic structural defect associated with the original
mutation since both double mutant proteins, Pma1-D378T/
L151F and Pma1-D378T/DC409-A412, presented the punctate
staining pattern similar to the one described for the Pma1-D378T
mutant protein, indicating that the suppression mechanism does
not improve the mutants capacity to exit the ER and traffic to the
plasma membrane. In contrast, an allele non-specific intragenic
suppressor, P536L, was found to suppress several dominant lethal
PMA1 alleles, D378N and D378E among others, but not D378T,
by a mechanism involving an improved folding of the mutant
protein that alleviates its ER-retention and favors its transport to
the plasma membrane [43]. This mechanism of suppression was
also described for second-site mutations A165V and A169I/
D170N, able to suppress dominant lethal mutant PMA1-K474R
[44]. More recently, a similar intragenic suppressor screen was
performed for YOR1-I1084P, a mutation that induces misfolding
and ER-retention of the transmembrane protein Yor1. The
suppressor mutations found in that case were able to partially
rescue the assembly defect caused by the primary change and
restored the capacity of the protein to exit the ER [45].
Nonetheless, we did observe a change regarding the subcellular
localization of the co-expressed wild type Pma1 that was now able
to reach the plasma membrane, providing an explanation for the
suppression of the inability to grow on galactose of the original
mutant. To try to understand the structural defect that impedes
normal traffic of the double mutant proteins to the plasma
membrane we analyzed the assembly state of the mutant and co-
expressed wild type proteins. Previous results had shown that
Pma1-D378T does not form a normal oligomer with wild type
Pma1, but instead the misfolded protein interferes with the folding
of the wild type leading to the formation of aggregates that are
insoluble even in SDS as revealed by BN-PAGE [28]. When this
type of analysis was performed with the double mutant proteins
Pma1-D378T/L151F and Pma1-D378T/DC409-A412, we ob-
served that the co-expressed wild type recovered almost com-
pletely the wild type pattern, as shown by the presence of the
monomeric and oligomeric bands characteristic of Pma1 from
Triton X-100 membranes. This rescue of the co-expressed wild
type protein is consistent with its detection at the plasma
membrane, and contrasts with the behavior of the accompanying
double mutant proteins that form insoluble aggregates as those
formed by Pma1-D378T and are unable to reach the cellular
surface. In the light of these and previous results it can be
concluded that at least two different suppression mechanisms exist
for dominant lethality. One of them improves the folding of the
revertant protein and favors its transport to the plasma membrane,
as exemplified by mutations P536L, A165V and A169I/D170N
[43], [44]. The other mechanism, shown by the L151F and
DC409-A412 mutations described here, does not rescue the
folding and trafficking of the aberrant dominant lethal protein but
disrupts the formation of oligomers between the mutant and wild
type enzymes allowing wild type Pma1 to exit the ER and traffic to
the plasma membrane, while the revertant enzyme remains
aggregated in the ER. A similar way of suppression is used by the
previously described Trp859stop mutation [28]. Thus, the
suppressor mutations found for the D378T mutation in two
independent genetic screenings share the suppression mechanism.
The single missense mutation L151F rendered a Pma1 variant
whose stability and final localization in the plasma membrane are
very similar to that of the wild type protein. When analyzed by
BN-PAGE, it showed the monomeric and oligomeric wild type
forms in TritonX-100 treated membranes, as opposed to Pma1-
DC409-A412 that presented high molecular weight aggregates
insoluble in SDS as the double mutants did.
Leu151 lies in the middle of the predicted segment TM2 within
the primary sequence: WVDFGVICGLLMLNAGVGFV. A
number of mutations in TM2 were recovered as second-site
revertants of different primary mutations, for instance mutations
I147M and C148S were found to suppress S368F, a mutation
located in close vicinity to D378T, (see [18], for a review). These
and other genetic data obtained by site-directed mutagenesis [46]
Figure 9. Analysis of the protein complexes formed by wild type and mutant Pma1 variants. A) Total membranes from yeast strains
expressing HA-tagged wild type Pma1 and myc-tagged wild type Pma1 (lanes 1,3, 9 and 11), dominant lethal myc-Pma1-D378T (lanes 2, 4, 10, and
12), double mutant protein myc-Pma1-D378T/L151F (lanes 5, 7, 13, and 15) or myc-Pma1-D378T/DC409-A412 (lanes 6, 8, 14 and 16) were treated with
3% Triton X-100 (lanes 1, 2, 5, 6, 9, 10, 13 and 14) or 1% SDS (lanes (3, 4, 7, 8, 11, 12, 15 and 16) as described in Materials and Methods. The solubilized
proteins were separated by BN-PAGE in duplicated gels and immunoblotted with anti-HA (lanes 1–8) or anti-myc (lanes 9–16) antibodies. The relative
mobilities of molecular mass markers are indicated on the left. B) Total membranes from yeast strains expressing myc-tagged wild type Pma1 and
single mutant protein HA-Pma1-L151F (lanes 1, 3, 5 and 7) or HA-Pma1-DC409-A412 (lanes 2, 4, 6 and 8) were treated with Triton X-100 (lanes 1, 2, 5
and 6) or 1% SDS (lanes (3, 4, 7 and 8) and the solubilized proteins separated by BN-PAGE and immunoblotted with anti-myc (lanes 1–4) or anti-HA
(lanes (5–8).
doi:10.1371/journal.pone.0067080.g009
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have led to the notion that TM1 and TM2 form a conformation-
ally sensitive hairpin structure. However a silent change in these
helices is not unprecedented since a mutation F120W, in TM1,
gave a fully functional enzyme [46]. On the other hand, when this
change is present in the D378T allele the resultant double mutant
protein is unable to oligomerize with the wild type Pma1, as shown
by the BN-PAGE analysis, pointing to a possible role for TM2 in
the intramembrane assembly process between monomers. Cys409
is in the central hydrophilic domain of the protein, located
between the phosphorylation site, Asp387, and the N-domain. In a
study dedicated to the role of cysteine residues in the structure and
function of Pma1 [41] it was found that a substitution C409A
enhanced the reactivity of another cysteine residue, Cys532,
towards N-Ethylmaleimide. The C409A change also increased the
sensitivity to fluorescein 59-isothiocyanate, an inhibitor of ATPase
known to react quite specifically with Lys474. This work suggests
that a C409A substitution leads to a conformational change in this
region of the protein. More recently, the role of the large
hydrophilic domain in Pma1 oligomerization has been addressed
by studying the association state of this domain expressed in E.coli
[47], reaching the conclusion that the phosphorylation domain
plays a fundamental role in the dimerization process. Taking these
data into account we propose that the 4 amino acids deletion in
this region present in the proteins Pma1-D378T/DC409-A412
and Pma1-DC409-A412, alters the conformation of the protein in
such a way that disrupts the interaction with the co-expressed wild
type Pma1.
The two second-site mutations identified in this work have the
common effect of altering the conformation of the mutant proteins
and interfering with the oligomerization process that precedes ER
export of Pma1. The location of these mutations suggests the
involvement of TM2 and P-domain in the assembly of the Pma1
oligomers.
Supporting Information
Figure S1 Suppression of dominant lethal mutations
PMA1-D560N and PMA1-R695L. Drop test for growth on
galactose of yeast strains carrying the indicated PMA1 alleles.
Yeast strain BY4741 was transformed with centromeric plasmid
pRS316 carrying GAL1-driven PMA1, PMA1-D560N, PMA1-
R695L, pma1-D560N/L151F, pma1-D560N/DC409-A412, pma1-
R695L/L151F or pma1-R695L/DC409-A412 alleles. The differ-
ent transformants were grown in SR medium for 24 h, suspended
in water to an OD660 = 0.1 and 5 ml were dropped on SD and SG
agar plates. Identical results were obtained with three independent
transformants. To create the double mutants containing L151F
and either D560N or R695L mutations, a 3,4 kb BstEII-HindIII
DNA fragment containing the dominant lethal mutations, was
excised from the PMA1-D560N or PMA1-R695L genes and cloned
into the same sites of pRS316-GAL1-HA-pma1-L151F. Site-
directed mutagenesis was used to introduce the D560N and
R695L mutations respectively in a 4.3 kb XhoI-HindIII fragment
containing the HA-tagged pma1-DC409-A412 gene subcloned into
pSK vector. The new PMA1 mutants were cloned into pRS316 in
which GAL1 promoter had been previously introduced.
(TIF)
Figure S2 Stability of the Pma1 mutants in ubc7
background. Yeast strain BY4741MATa his3D1 leu2D0 met15D0
ura3D0 YMR022w::kanMX4 carrying a disruption in UBC7 was
purchased from EUROSCARF and transformed with centromeric
plasmid pRS315 carrying GAL1-driven myc-PMA1-D378T or
double mutant alleles myc-pma1-D378T/L151F and myc-pma1-
D378T/DC409-A412. The transformants were grown in SR
medium and derepressed in galactose containing medium for 4 h
to induce the expression of the different PMA1 alleles. After
addition of cycloheximide, samples were taken at the indicated
times and total yeast membranes prepared and analyzed by
Western blot with anti-myc antibodies. A representative blot of
two cycloheximide-chase experiments is shown. Densitometric
analysis of the Western blots is also shown. Remaining Pma1 at
different times was referred to the amount before adding
cycloheximide (t = 0) and the average of the two experiments is
shown. Dashed lines representing the results of the same
experiment performed in wild type background (Figure 4) are
included here for comparison. Pma1-D378T (circles), Pma1-
D378T/L151F (squares), Pma1-D378T/DC409-A412 (triangles).
(TIF)
Acknowledgments
We thank Irene Rubio and Irene Oza´ez for their help with some of the
experiments.
Author Contributions
Conceived and designed the experiments: FP MJM. Performed the
experiments: PE MJM. Analyzed the data: PE FP MJM. Contributed
reagents/materials/analysis tools: PE FP MJM. Wrote the paper: FP MJM.
References
1. Serrano R, Kielland-Brandt MC, Fink GR (1986) Yeast plasma membrane
ATPase is essential for growth and has homology with (Na++K+), K+- and
Ca2+-ATPases. Nature 319: 689–693.
2. Catty P, de Kerchove d’Exaerde A, Goffeau A (1997) The complete inventory of
the yeast Saccharomyces cerevisiae P-type transport ATPases. FEBS Lett 409:
325–332.
3. Serrano R (1991) Transport across yeast vacuolar and plasma membrane. The
Molecular and Cellular Biology of the Yeast Saccharomyces : Genome,
Dynamics, Protein Synthesis and Energetics. Cold Spring Harbor, N.Y. : Cold
Spring Harbor Laboratory Press. 523–585.
4. Bukrinsky JT, Buch-Pedersen MJ, Larsen S, Palmgren MG (2001) A putative
proton binding site of plasma membrane H(+)-ATPase identified through
homology modelling. FEBS Lett 494: 6–10.
5. Kuhlbrandt W (2004) Biology, structure and mechanism of P-type ATPases. Nat
Rev Mol Cell Biol 5: 282–295.
6. Pedersen BP, Buch-Pedersen MJ, Morth JP, Palmgren MG, Nissen P (2007)
Crystal structure of the plasma membrane proton pump. Nature 450: 1111–
1114.
7. Portillo F (2000) Regulation of plasma membrane H(+)-ATPase in fungi and
plants. Biochim Biophys Acta 1469: 31–42.
8. Eraso P, Cid A, Serrano R (1987) Tight control of the amount of yeast plasma
membrane ATPase during changes in growth conditions and gene dosage. FEBS
Lett 224: 193–197.
9. Eraso P, Mazo´n MJ, Posas F, Portillo F (2011) Gene expression profiling of
yeasts overexpressing wild type or misfolded Pma1 variants reveals activation of
the Hog1 MAPK pathway. Mol Microbiol 79: 1339–1352.
10. de Kerchove d’Exaerde A, Supply P, Goffeau A (1996) Review: subcellular
traffic of the plasma membrane H(+)-ATPase in Saccharomyces cerevisiae.
Yeast 12: 907–916.
11. Ambesi A, Miranda M, Petrov VV, Slayman CW (2000) Biogenesis and function
of the yeast plasma-membrane H(+)-ATPase. J Exp Biol 203: 155–160.
12. Lee MC, Hamamoto S, Schekman R (2002) Ceramide biosynthesis is required
for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic
reticulum. J Biol Chem 277: 22395–22401.
13. Bagnat M, Chang A, Simons K (2001) Plasma membrane proton ATPase
Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell 12:
4129–4138.
14. Wang Q, Chang A (2002) Sphingoid base synthesis is required for
oligomerization and cell surface stability of the yeast plasma membrane
ATPase, Pma1. Proc Natl Acad Sci U S A 99: 12853–12858.
15. Gaigg B, Toulmay A, Schneiter R (2006) Very long-chain fatty acid-containing
lipids rather than sphingolipids per se are required for raft association and stable
Second-Site Mutations Prevent Aggregation of Pma1
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e67080
surface transport of newly synthesized plasma membrane ATPase in yeast. J Biol
Chem 281: 34135–34145.
16. Toulmay A, Schneiter R (2007) Lipid-dependent surface transport of the proton
pumping ATPase: a model to study plasma membrane biogenesis in yeast.
Biochimie 89: 249–254.
17. Harris SL, Na S, Zhu X, Seto-Young D, Perlin DS, et al. (1994) Dominant lethal
mutations in the plasma membrane H(+)-ATPase gene of Saccharomyces
cerevisiae. Proc Natl Acad Sci U S A 91: 10531–10535.
18. Morsomme P, Slayman CW, Goffeau A (2000) Mutagenic study of the structure,
function and biogenesis of the yeast plasma membrane H(+)-ATPase. Biochim
Biophys Acta 1469: 133–157.
19. Portillo F (1997) Characterization of dominant lethal mutations in the yeast
plasma membrane H+-ATPase gene. FEBS Lett 402: 136–140.
20. DeWitt ND, dos Santos CF, Allen KE, Slayman CW (1998) Phosphorylation
region of the yeast plasma-membrane H+-ATPase. Role in protein folding and
biogenesis. J Biol Chem 273: 21744–21751.
21. Nakamoto RK, Verjovski-Almeida S, Allen KE, Ambesi A, Rao R, et al. (1998)
Substitutions of aspartate 378 in the phosphorylation domain of the yeast PMA1
H+-ATPase disrupt protein folding and biogenesis. J Biol Chem 273: 7338–
7344.
22. Wang Q, Chang A (1999) Eps1, a novel PDI-related protein involved in ER
quality control in yeast. EMBO J 18: 5972–5982.
23. Mazo´n MJ, Eraso P, Portillo F (2007) Efficient degradation of misfolded mutant
Pma1 by endoplasmic reticulum-associated degradation requires Atg19 and the
Cvt/autophagy pathway. Mol Microbiol 63: 1069–1077.
24. Loayza D, Tam A, Schmidt WK, Michaelis S (1998) Ste6p mutants defective in
exit from the endoplasmic reticulum (ER) reveal aspects of an ER quality control
pathway in Saccharomyces cerevisiae. Mol Biol Cell 9: 2767–2784.
25. Kostova Z, Wolf DH (2003) For whom the bell tolls: protein quality control of
the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J
22: 2309–2317.
26. Ahner A, Brodsky JL (2004) Checkpoints in ER-associated degradation: excuse
me, which way to the proteasome? Trends Cell Biol 14: 474–478.
27. Liu Y, Sitaraman S, Chang A (2006) Multiple degradation pathways for
misfolded mutants of the yeast plasma membrane ATPase, Pma1. J Biol Chem
281: 31457–31466.
28. Eraso P, Mazo´n MJ, Portillo F (2010) A dominant negative mutant of PMA1
interferes with the folding of the wild type enzyme. Traffic 11: 37–47.
29. Adams A, Gottschling DE, Kaiser CA, Stearns T (1997) Methods in Yeast
Genetics. New York: Cold Spring Harbor Laboratory Press.
30. Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains
designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics 122: 19–27.
31. Zheng L, Baumann U, Reymond JL (2004) An efficient one-step site-directed
and site-saturation mutagenesis protocol. Nucleic Acids Res 32: e115.
32. Cid A, Perona R, Serrano R (1987) Replacement of the promoter of the yeast
plasma membrane ATPase gene by a galactose-dependent promoter and its
physiological consequences. Curr Genet 12: 105–110.
33. Gietz RD, Woods RA (2002) Transformation of yeast by lithium acetate/single-
stranded carrier DNA/polyethylene glycol method. Methods Enzymol 350: 87–
96.
34. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 227: 680–685.
35. Serrano R, Monk BC, Villalba JM, Montesinos C, Weiler EW (1993) Epitope
mapping and accessibility of immunodominant regions of yeast plasma
membrane H(+)-ATPase. Eur J Biochem 212: 737–744.
36. Bradford MM (1976) A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 72: 248–254.
37. Pringle JR, Adams AE, Drubin DG, Haarer BK (1991) Immunofluorescence
methods for yeast. Methods Enzymol 194: 565–602.
38. Schagger H, Cramer WA, von Jagow G (1994) Analysis of molecular masses and
oligomeric states of protein complexes by blue native electrophoresis and
isolation of membrane protein complexes by two-dimensional native electro-
phoresis. Anal Biochem 217: 220–230.
39. Mason AB, Allen KE, Slayman CW (2006) Effects of C-terminal truncations on
trafficking of the yeast plasma membrane H+-ATPase. J Biol Chem 281: 23887–
23898.
40. Monk BC, Feng WC, Marshall CJ, Seto-Young D, Na S, et al. (1994) Modeling
a conformationally sensitive region of the membrane sector of the fungal plasma
membrane proton pump. J Bioenerg Biomembr 26: 101–115.
41. Petrov VV, Pardo JP, Slayman CW (1997) Reactive cysteines of the yeast
plasma-membrane H+-ATPase (PMA1). Mapping the sites of inactivation by N-
ethylmaleimide. J Biol Chem 272: 1688–1693.
42. Ferreira T, Mason AB, Pypaert M, Allen KE, Slayman CW (2002) Quality
control in the yeast secretory pathway: a misfolded PMA1 H+-ATPase reveals
two checkpoints. J Biol Chem 277: 21027–21040.
43. Maldonado AM, de la Fuente N, Portillo F (1998) Characterization of an allele-
nonspecific intragenic suppressor in the yeast plasma membrane H+-ATPase
gene (Pma1). Genetics 150: 11–19.
44. Maldonado AM, Portillo F (1995) Genetic analysis of the fluorescein
isothiocyanate binding site of the yeast plasma membrane H(+)-ATPase. J Biol
Chem 270: 8655–8659.
45. Pagant S, Halliday JJ, Kougentakis C, Miller EA (2010) Intragenic suppressing
mutations correct the folding and intracellular traffic of misfolded mutants of
Yor1p, a eukaryotic drug transporter. J Biol Chem 285: 36304–36314.
46. Seto-Young D, Hall MJ, Na S, Haber JE, Perlin DS (1996) Genetic probing of
the first and second transmembrane helices of the plasma membrane H(+)-
ATPase from Saccharomyces cerevisiae. J Biol Chem 271: 581–587.
47. Almeida WI, Martins OB, Carvalho-Alves PC (2006) Self-association of isolated
large cytoplasmic domain of plasma membrane H+ -ATPase from Saccharo-
myces cerevisiae: role of the phosphorylation domain in a general dimeric model
for P-ATPases. Biochim Biophys Acta 1758: 1768–1776.
Second-Site Mutations Prevent Aggregation of Pma1
PLOS ONE | www.plosone.org 9 June 2013 | Volume 8 | Issue 6 | e67080
